A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): Should defibrillation threshold testing be performed post-(MRI)

Journal of Interventional Cardiac Electrophysiology

Volumn 28, Issue 1, 2010, Pages 59-66

  Burke, Peter Thomas ^a   Ghanbari, Hamid ^a   Alexander, Patrick B ^a   Shaw, Michael K ^a   Daccarett, Marcos ^a   Machado, Christian ^a  

^a PROVIDENCE HOSPITAL   (United States)

Author keywords

Cardiac implantable electronic device; CIED; Defibrillation safety margin testing; Defibrillator threshold testing; DSMT; ICD; Magnetic resonance imaging; MRI; Pacemaker

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE; CLINICAL ARTICLE; CLINICAL PROTOCOL; DEFIBRILLATION THRESHOLD TESTING; DEFIBRILLATOR; DEFIBRILLATOR SAFETY MARGIN TESTING; ELECTRIC BATTERY; EVALUATION; FEASIBILITY STUDY; HEART PACING; HUMAN; IMPEDANCE; IMPLANT; NUCLEAR MAGNETIC RESONANCE IMAGING; PACEMAKER; PATIENT MONITORING; PATIENT SAFETY; PRIORITY JOURNAL; REPRODUCIBILITY; SHOCK;

CARDIOVASCULAR DISEASES; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; EQUIPMENT FAILURE ANALYSIS; EQUIPMENT SAFETY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PACEMAKER, ARTIFICIAL; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PROBABILITY; RISK ASSESSMENT; RISK MANAGEMENT; STATISTICS, NONPARAMETRIC; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77954956749     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-009-9463-y     Document Type: Article

References (31)

1. Luechinger, R., Zeijlemaker, V. A., et al. (2005). In vivo heating of pacemaker leads during magnetic resonance imaging. European Heart Journal, 26, 376-383. (Pubitemid 40283097)
2. Pinski, S. L., Trohman, R. G., et al. (2002). Interference in implantable cardiac devices, part II (review). Pacing and Clinical Electrophysiology, 25(10), 1496-1509
3. Gimbel, R., Bailey, S., et al. (2005). Strategies for the safe magnetic resonance imaging of pacemaker-dependant patients. Pacing and Clinical Electrophysiology, 28, 1041-1046.
4. Martin, E. T., Coman, J. A., et al. (2004). Magnetic resonance imaging and cardiac pacemaker safety at 1.5 Tesla. Journal of the American College of Cardiology, 43, 1315-1324.
5. Roguin, A., Zviman, M., et al. (2004). Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic imaging safe. in vitro and in vivo assesment of safety and function at 1.5 T. Circulation, 110, 475-482.
6. Derek, V. E. (2005). Is antitachycardia pacing a safe and efficacious alternative to shocks for fast ventricular tachyarrhythmia treatment? Nature Clinical Practice Cardiovascular Medicine, 2, 68-69.
7. Martin, E. T. (2005). Can cardiac pacemakers and magnetic resonance imaging systems co-exist? European Heart Journal, 26, 325-327.
8. Shellock, F., Fieno, D., et al. (2006). Cardiac pacemeaker: in vitro assesment at 1.5 T. American Heart Journal, 151, 436-443.
9. Gimbel, J. R. (2008). Magnetic resonance imaging of implantable cardiac rhythm Devicesat 3.0 Tesla. Pacing and Clinical Electrophysiology, 31, 795-801.
10. Sierra, M., &Machado, C. (2008). Magnetic resonance imaging in patients with implantable cardiac devices. Review in Cardiovascular Medicine, 9(4), 232-238.
11. Levine, G., Gomes, A., et al. (2007). Safety of magnetic resonance imaging in patients with cardiovascular devices. Circulation, 116, 2878-2891.
12. Gimbel, J. R., Kanal, E., et al. (2005). Outcomes of Magnetic Resonance Imaging (MRI) in selected patients with Implantable Cardioverter Defibrillators (ICD). Pacing and Clinical Electrophysiology, 28, 270-273.
13. Roguin, A., Schwitter, J., Vahlhaus, C., Lombardi, M., Priori, S., &Sommer, T. (2008). ESC position paper-magnetic resonance imaging in individuals with pacemakers or implantable cardioverter defibrillator systems. Europace, 10, 336-346.
14. Gold, M., Breiter, D., &Hahn, S. (2003). Safety of a single successful conversion of ventricular fibrillation before the implantation of cardioverter-defibrillators. Pacing and Clinical Electrophysiology, 26, 483-486.
15. Higgins, S., Mann, D., Calkins, H., et al. (2005). One conversion of ventricular fibrillation is adequate for implantable cardioverterdebibrillator. An analysis from the low energy safety study (LESS). Heart Rhythm, 2, 117-122.
16. Gimbel, J. R., &Kanal, E. (2004). Can patients with implantable pacemakers safely undergo magnetic resonance imaging? Journal of the American College of Cardiology, 43, 1325-1327.
17. Rozner, M. A., Burton, A. W., &Kumar, A. (2005). Pacemaker complication during magnetic resonance imaging. Journal of the American College of Cardiology, 45, 161-162.
18. Shellock, F. G., O'Neil, M., et al. (1999). Cardiac pacemeakers and implantable cardioverter defibrillators are unaffected by operation of extremity MR imaging system. American Journal of Roentgenology, 172, 165-170.
19. Naehle, C. P., Zeijlemaker, V., Thomas, D., Meyer, C., Strach, K., Fimmers, R., et al. (2009). Evaluation of cumulative effects of MR imaging on pacemaker systems at 1.5 Tesla. Pacing and Clinical Electrophysiology, 32(12), 1526-1535.
20. Naehle, C. P., Meyer, C., Thomas, D., Remerie, S., Krautmacher, C., Litt, H., et al. (2008). Safety of brain 3-T MR imaging with transmit-receive head coil in patients with cardiac pacemakers: pilot prospective study with 51 examinations. Radiology, 249(3), 991-1001.
21. Naehle, C. P., Strach, K., Thomas, D., Meyer, C., Linhart, M., Bitaraf, S., et al. (2009). Magnetic resonance imaging at 1.5 Tesla in patients with implantable cardioverters/defibrillators. Journal of the American College of Cardiology, 54(6), 549-555.
22. Hayes, D. L., Holmes, D. R., Jr., et al. (1987). Effect of 1.5 Tesla nuclear magnetic resonance imaging scanner on implanted permanent pacemakers. Journal of the American College of Cardiology, 10(4), 782-786.
23. Holmes, D. R., Jr., Hayes, D. L., et al. (1986). The effects of magnetic resonance imaging on implantable pulse generators. Pacing and Clinical Electrophysiology, 9(3), 360-370.
24. Luechinger, R., Duru, F., et al. (2001). Force and torque effects of a 1.5-Tesla MRI scanner on cardiac pacemakers and ICDs. Pacing and Clinical Electrophysiology, 24(2), 199-205.
25. Gimbel, J. R. (2008). The AHA scientific statement of MRI in patients with devices: neat, but incomplete. Unwise and unsupported. Pacing and Clinical Electrophysiology, 31(6), 649-651.
26. Coman, J. A., Martin, E. T., et al. (2004). Implantable cardiac defibrillator interactions with magnetic resonance imaging at 1.5 Tesla. Journal of the American College of Cardiology, 43, 138A.
27. Sandler, D. A., Coman, J. A., et al. (2006). Magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators in a 1.5-Tesla magnet: A five-year experience. Heart Rhythm Society, 27th Annual Scientific Sessions, Boston, MA: May 17-20, 2006
28. Fiek, M., Remp, T., Reithmann, C., &Steinbeck, G. (2004). Complete loss of ICD programmability after magnetic resonance imaging. Pacing and Clinical Electrophysiology, 27, 1002-1004.
29. Glikson, M., Luria, D., et al. (2000). Are routine arrhythmia inductions necessary in patients with pectoral implantable cardioverter defibrillators? Journal of Cardiovascular Electrophysiology, 2, 127-135.
30. Nazarian, S., Roguin, A., Zviman, M. M., Lardo, A. C., Dickfeld, T. L., Calkins, H., et al. (2006). Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 Tesla. Circulation, 114, 1277-1284.
31. Birnie, D., Tung, S., Simpson, C., Crystal, E., Exner, D., Ayala Paredes, F. A., et al. (2008). Complications associated with defibrillation threshold testing: the Canadian experience. Heart Rhythm, 5(3),387-390.